IRIS
PAOLILLO, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.384
NA - Nord America 4.584
EU - Europa 3.765
SA - Sud America 692
AF - Africa 190
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 15.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.398
SG - Singapore 2.641
RU - Federazione Russa 1.755
VN - Vietnam 1.269
CN - Cina 1.092
IT - Italia 721
HK - Hong Kong 648
BR - Brasile 544
DE - Germania 275
FR - Francia 197
NL - Olanda 195
FI - Finlandia 182
JP - Giappone 136
IN - India 127
CA - Canada 100
GB - Regno Unito 100
BD - Bangladesh 86
IE - Irlanda 65
AR - Argentina 63
CI - Costa d'Avorio 63
UA - Ucraina 63
KR - Corea 61
MX - Messico 57
SE - Svezia 54
PH - Filippine 49
IQ - Iraq 41
ZA - Sudafrica 39
TH - Thailandia 32
PL - Polonia 31
ID - Indonesia 28
PK - Pakistan 26
TR - Turchia 25
AT - Austria 20
EC - Ecuador 19
ES - Italia 19
UZ - Uzbekistan 17
CO - Colombia 16
TW - Taiwan 16
RO - Romania 15
JO - Giordania 13
AU - Australia 10
BE - Belgio 10
CL - Cile 10
EG - Egitto 10
KE - Kenya 10
MA - Marocco 10
PY - Paraguay 10
TN - Tunisia 10
DZ - Algeria 9
LT - Lituania 9
NP - Nepal 9
VE - Venezuela 9
IL - Israele 8
JM - Giamaica 8
AL - Albania 7
CZ - Repubblica Ceca 7
PE - Perù 7
PT - Portogallo 7
SN - Senegal 7
BO - Bolivia 6
ET - Etiopia 6
MY - Malesia 6
NZ - Nuova Zelanda 6
SA - Arabia Saudita 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BG - Bulgaria 5
CH - Svizzera 5
CR - Costa Rica 5
GE - Georgia 5
GR - Grecia 5
IR - Iran 5
SK - Slovacchia (Repubblica Slovacca) 5
LB - Libano 4
PS - Palestinian Territory 4
DO - Repubblica Dominicana 3
EU - Europa 3
LK - Sri Lanka 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
GA - Gabon 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
ML - Mali 2
NG - Nigeria 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
SR - Suriname 2
TJ - Tagikistan 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
Totale 15.602
Salva come PNG Salva come JPEG
Città #
Singapore 1.321
San Jose 966
Hong Kong 610
Ashburn 440
Moscow 424
Ho Chi Minh City 365
Beijing 332
Hanoi 279
Chandler 261
Hefei 227
Santa Clara 174
Los Angeles 173
Amsterdam 150
Naples 150
Lauterbourg 141
Tokyo 108
Dallas 104
Millbury 104
The Dalles 101
Napoli 91
Boston 75
Munich 73
Princeton 69
New York 67
Turku 67
Des Moines 59
Seattle 59
Council Bluffs 58
São Paulo 57
Buffalo 54
Helsinki 53
Redondo Beach 53
Frankfurt am Main 52
Haiphong 52
Nanjing 47
Ottawa 47
Seoul 44
Da Nang 42
Orem 37
Lawrence 35
Pune 32
Milan 31
Wilmington 31
Atlanta 30
Brooklyn 30
Nuremberg 26
Warsaw 26
Mexico City 25
Houston 24
Biên Hòa 23
Stockholm 21
Johannesburg 20
Baghdad 18
Chicago 18
Hải Dương 18
London 18
Rome 18
Montreal 17
Can Tho 16
Changsha 16
Chennai 16
Tashkent 16
Boardman 15
Dhaka 15
Toronto 15
Falkenstein 14
Jacksonville 14
Poplar 14
Belo Horizonte 13
Krefeld 13
Mumbai 13
Nanchang 13
Rio de Janeiro 13
Tianjin 13
Hebei 12
San Francisco 12
Shanghai 12
Shenyang 12
Amman 11
Ankara 11
Bangkok 11
Manchester 11
Phoenix 11
Tân Tiến 11
Denver 10
Guangzhou 10
Kochi 10
New Delhi 10
Norwalk 10
Vienna 10
Bologna 9
Bắc Giang 9
Bắc Ninh 9
Bến Tre 9
Curitiba 9
Düsseldorf 9
Fortaleza 9
Jiaxing 9
Nairobi 9
Quảng Ngãi 9
Totale 8.540
Salva come PNG Salva come JPEG
Nome #
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT) 261
123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation 214
Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis 190
Una insospettabile signora chiamata disfunzione diastolica 187
Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue 170
null 168
Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure 167
Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure 162
Sleep-disordered breathing and epicardial adipose tissue in patients with heart failure. 161
Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure 159
Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure 158
Validation of the echocardiographic assessment of epicardial adipose tissue thickness at the Rindfleisch fold for the prediction of coronary artery disease 153
Cardiac sympathetic innervation and mortality risk scores in patients with heart failure 151
Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure 150
Impact of Gender in Primary Prevention of Coronary Heart Disease With Statin Therapy: A Meta-Analysis 147
Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure 147
Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study 146
Impact of aging on cardiac sympathetic innervation measured by (123)I-mIBG imaging in patients with systolic heart failure 146
Expert Review on the Prognostic Role of Echocardiography after Acute Myocardial Infarction 144
Hypertrophic cardiomyopathy in mitochondrial disorders: description of an uncommon clinical case 143
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry 142
Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications. 142
MicroRNAs: diagnostic, prognostic and therapeutic role in heart failure—a review 141
Prognostic role of transthoracic echocardiography in patients affected by heart failure and reduced ejection fraction 141
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset 139
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry 139
Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal 136
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 135
Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis 135
Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients 134
Impact of body mass index on cardiac adrenergic derangement in heart failure patients: a 123I-mIBG imaging study 134
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. 133
Left Ventricular Function, Epicardial Adipose Tissue, and Carotid Intima-Media Thickness in Children and Adolescents With Vertical HIV Infection 133
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry 133
Artificial intelligence in cardiology: a peek at the future and the role of ChatGPT in cardiology practice 133
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base 132
Renal function and cardiac adrenergic impairment in patients affected by heart failure 130
The role of metabolic syndrome in heart failure 129
Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials. 129
Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart Failure 129
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies 129
Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry 128
Epidemiologia e Prevenzione 127
[European guidelines on cardiovascular disease prevention: what's new?] 125
Italian Society of Cardiology-Italian Society of Nephrology Consensus Document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage 123
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure 123
Ruolo della scintigrafia miocardica perfusionale e dell’ecocardiografia per la diagnosi di coronaropatia in pazienti ipertesi: metanalisi 122
Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration 121
Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with Hormonal Deficiencies 121
Crosslink between atrial fibrillation and cancer: a therapeutic conundrum 121
The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit 119
Prevalenza di disturbi del sonno in pazienti affetti da cardiomiopatia dilatativa e severa riduzione della funzione ventricolare sinistra 119
Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry 118
Nuclear Assessment of Right Ventricle 118
Prognostic Value of Hormonal Abnormalities in Heart Failure Patients. 118
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 117
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 115
Heart rate during exercise: mechanisms, behavior, and therapeutic and prognostic implications in heart failure patients with reduced ejection fraction 115
Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis 112
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. 112
Heart failure and anemia: Effects on prognostic variables. 112
Serum levels of pro-B-type natriuretic peptide predict reduced left atrial function in patients with systolic heart failure 111
The metabolic syndrome in heart failure: insights to specific mechanisms. 111
Novel Strategies in Diagnosing Heart Failure with Preserved Ejection Fraction: A Comprehensive Literature Review 110
Statin therapy in patients with subclinical and evident peripheral artery disease: a meta-analysis 109
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 109
Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079)) 108
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population) 107
Nuove prospettive nella riduzione del rischio cardiovascolare: Focus su HDL 107
Cardiovascular disease and psychiatric disorders: An-up-to date review 106
Innovations in medical therapy of heart failure with reduced ejection fraction 105
Diagnostic algorithms in patients with suspected coronary artery disease. Guidelines and evidence-based behaviours. 104
Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal 103
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database. 103
Associazione tra disfunzione endoteliale ed ischemia miocardica silente in pazienti con arteriopatia periferica 102
Vitamin D deficiency and clinical outcome in patients with chronic heart failure: a review 102
Prognostic value of indeterminable anaerobic threshold in heart failure. 102
Glucose Metabolism Abnormalities in Heart Failure Patients: Insights and Prognostic Relevance. 101
Depression in Heart Failure with Reduced Ejection Fraction, an Undervalued Comorbidity: An Up-To-Date Review 100
Cardiorenal syndrome: Pathophysiology as a key to the therapeutic approach in an under-diagnosed disease 100
Endothelial-dependent microvascular dysfunction in type II diabetic patients without significant coronary artery stenosis. Effects on myocardial perfusion 99
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study. 99
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 98
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology 98
The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis 96
Il rischio cardiovascolare nelle patologie infiammatorie sistemiche 96
Choosing among β-blockers in heart failure patients according to β-receptors’ location and functions in the cardiopulmonary system 96
Rest-redistribution 201T1 SPECT predicts myocardial infaretion and cardiac death in patients with ischernic left ventricular dysfunction 94
Left ventricular hypertrophy reduction and clinical events. A meta-regression analysis of 14 studies in 12,809 hypertensive patients 94
Observer reproducibility of results from a low-dose (123)I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure 94
Prognostic impact of diabetes in chronic and acute heart failure 94
Changes of urinary albumin excretion and cardiovascular events: a meta-regression analysis of 32 randomized trials and 80,812 patients. 93
Nuclear imaging in detection and monitoring of cardiotoxicity 90
Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients. 89
Cardiovascular effects of antiretroviral drugs: clinical review. 88
Endothelial dysfunction in type 2 diabetic patients with normal coronary arteries A digital reactive hyperemia study. 88
Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice 87
Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials 87
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology 86
Ischemic heart disease in systemic inflammatory diseases. An appraisal 86
Totale 12.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022523 14 4 4 11 9 9 12 15 67 36 97 245
2022/2023858 103 13 28 31 107 80 26 69 123 143 106 29
2023/2024772 31 99 96 40 49 92 16 123 8 37 125 56
2024/20253.954 166 154 10 37 118 255 433 258 289 404 1.476 354
2025/20268.956 849 603 819 728 1.430 418 1.459 561 1.216 595 248 30
Totale 15.916